Global Market Pipeline for Vaccine Technologies 2024-2028

News provided by

Feb 08, 2024, 10:15 ET

DUBLIN, Feb. 8, 2024 /PRNewswire/ -- The "Global Markets for Vaccine Technologies" report has been added to ResearchAndMarkets.com's offering.

Advancements will occur in regard to the development of novel vaccines towards emerging infectious diseases, cancers and allergies. Continuous improvements in vaccine design, delivery technologies and manufacturing will also boost market growth.

The global vaccine technologies market is segmented in this report by technology, disease, age, and region. This report explains critical trends in the vaccine industry. It discusses the market determinants, which act as motivating or restraining factors and provides insights to stakeholders and potential entrants.

This report includes only human vaccines; animal vaccines have not been considered in this report. This study looks at research and development (R&D) spending, increasing competition and new technologies, which are giving direction to the market. These advancements, new product launches and changing lifestyles are influencing future market growth.

Company mergers, acquisition strategies and collaborations are also covered in this report. Additionally, this study discusses the strengths and weaknesses of each strategy type, considering new technologies, growing competition and changing customer needs.

The market has been analyzed based on the application of current vaccines. Categories considered in this report include pneumococcal vaccines; diphtheria, tetanus vaccines; HPV vaccines; MMR vaccines; and other vaccines including rotavirus vaccines, influenza vaccines, hepatitis B vaccines, chickenpox vaccines, polio vaccines, BCG, and yellow fever vaccines.

This study details market growth among vaccine manufacturers and end users. Genomic research centers, academic institutions, government and private laboratories, various hospital settings, and pharmaceutical, diagnostic and biotechnology companies and physicians will find this study to be of interest.

This report provides useful information to all market players, potential entrants, government agencies and other interested parties. As the report covers geographic regions in detail, companies interested in expanding geographic reach will also find this study useful.

The Report Includes

34 data tables and 63 additional tables
An up-to-date overview of the global markets for vaccine technologies
Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
Estimate of the market size and revenue forecast for the global market, and a corresponding market share analysis based on technology, disease indication, age group and region
Facts and figures pertaining to the market drivers, opportunities and challenges, emerging technologies, global R&D spending, and the regulatory landscape
Assessment of present and future strategies in the innovation-driven vaccine technologies market, and a look at the vaccines for humans and their immunization schedule
Discussion of the importance of ESG in the market for vaccine technologies, including consumer attitudes, the impact of ESG factors on company performance, and ESG practices of leading companies
Review of patents and patent applications
Overview of the major vendors, along with an analysis of the industry structure, including company market shares, recent M&A activity, and venture funding
Analysis of the competitive landscape based on recent developments and segmental revenues
Profiles of the leading companies

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Immune System and Vaccines
Components of the Immune System
Cells of the Immune System
Immune Response
Major Histocompatibility Complex (MHC)
Immunization and Vaccines
Disorders of the Immune System
Impact of Lifestyle on the Immune System
How Vaccines Work
Principles of Immunization
Types of Immunity
Advantages of Vaccination
History of Vaccines
Vaccines and Immunization, Overview
Types of Vaccines
Attenuated (Live) Vaccines
Inactivated (Killed) Vaccines
Toxoid Vaccines
Subunit Vaccines
Conjugate Vaccines
Recombinant Vector Vaccines
DNA Vaccines
RNA Vaccines
Immunization
Advantages of Immunization
Adjuvants and Excipients
Pathogen Components
Particulate Adjuvants
Infectious Diseases Preventable by Vaccine
Human Diseases
Viral Diseases
Bacterial Diseases
Regulatory Aspects
World Health Organization (WHO) Prequalified Vaccines
New Product Approvals
Recalls
Significant Regulatory Developments in Vaccines

Chapter 4 Market Dynamics

Market Drivers
- Growing Awareness of Immunization
- Growing Investments and R&D
- New Vaccines
- Prevalence of Infectious Diseases
Market Restraints
- Vaccine Development and Pricing
Market Opportunities
- Increased Demand from Emerging Markets
- Therapeutic Vaccines

Chapter 5 Global Market for COVID-19 Vaccines

COVID-19 Vaccine Technologies
Advent of mRNA Technology
Impact of COVID-19 on Routine Infant Vaccination
COVID-19 Disruptions
Stagnating Global Coverage Rate
Progress and Challenges by Country and Region

Chapter 6 Market Breakdown by Technology

Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines
Live-Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Other/Combination Vaccines

Chapter 7 Market Breakdown by Disease

Pneumococcal
Diphtheria and Tetanus
HPV
MMR

Chapter 8 Market Breakdown by Age Group

Pediatrics
Adolescents and Adults

Chapter 9 Market Breakdown by Region

Chapter 10 Emerging Technologies and Developments

Developments
mRNA Vaccines
Viral Vector Vaccines
Nanoparticle Vaccines
DNA Vaccines
Virus-Like Particle (VLP) Vaccines
Self-Amplifying RNA Vaccines
Innovative Adjuvants
AI and Computational Biology
Personalized Vaccines
Plant-Based Vaccines

Chapter 11 Competitive Landscape

Chapter 12 Company Profiles

Abbott
Astrazeneca
Bavarian Nordic
Bharat Biotech International
Emergent Biosolutions
GSK
Johnson & Johnson Services
Merck
Mitsubishi Tanabe Pharma Corp.
Panacea Biotec
Pfizer Inc.
Sanofi

For more information about this report visit https://www.researchandmarkets.com/r/squdpk

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets